• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • eedwards@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
  • DONATE
JOIN or RENEW HERE
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Barrett’s Esophagus
  • Celiac Disease
  • Crohn’s Disease
  • Eosinophilic Esophagitis
  • Gastroesophageal Reflux Disease
  • Intraductal Papillary Mucinous Neoplasms
  • Nonalcoholic Steatohepatitis
  • Primary Biliary Cholangitis
  • Primary Sclerosing Cholangitis
  • Ulcerative Colitis
  • Wilson’s Disease
  • All
  • Barrett’s Esophagus
  • Celiac Disease
  • Crohn’s Disease
  • Eosinophilic Esophagitis
  • Gastroesophageal Reflux Disease (GERD)
  • Intraductal Papillary Mucinous Neoplasms (IPMN)
  • Nonalcoholic Steatohepatitis (NASH)
  • Primary Biliary Cholangitis
  • Primary Sclerosing Cholangitis
  • Ulcerative Colitis
  • Wilson’s Disease
  • All
  • admin
January 31, 2022
Categories
  • Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH)

  Study title A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (Harmony) Disease or condition NASH-Nonalcoholic Steatohepatitis Study type Interventional  (Clinical […]
Do you like it?
Read more
January 31, 2022
Categories
  • Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH)

  Study title A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and […]
Do you like it?
Read more
September 10, 2021
Categories
  • Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH)

  Study title A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and […]
Do you like it?
Read more
May 31, 2021
Categories
  • Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH)

Study title HANMI: A Phase 2, Randomized, Double-Blind Study to Evaluate HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH; Protocol: HM-TRIA-201 Disease or […]
Do you like it?
Read more
May 31, 2021
Categories
  • Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH)

Study title Madrigal-11: A Phase 3, Multinational, Double-Blind, Randomized,Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With NASH and Fibrosis to Resolve NASH and reduce Progression to […]
Do you like it?
Read more
May 31, 2021
Categories
  • Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis (NASH)

Study title Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Disease or condition NASH Study type Interventional  (Clinical Trial) Intervention/treatment […]
Do you like it?
Read more

ADDRESS


801 E Morehead Street
Suite 110
Charlotte NC 28202

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


eedwards@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE